Quest Diagnostics’ Laboratory in India Accredited by Leading Laboratory Accrediting Organizations
Quest Diagnostics’ Laboratory in India Accredited by Leading Laboratory Accrediting Organizations

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic testing, information and services, today announced that its wholly-owned subsidiary Quest Diagnostics India Pvt. Ltd. has received certificates of accreditation from the College of American Pathologists (CAP), a leading international laboratory accrediting organization, and the National Accreditation Board for Testing and Calibration Laboratories (NABL), the sole government-authorized laboratory accreditation body in India, for its diagnostic and clinical trials laboratory in Gurgaon, India.

Emerging trends in Electronic Data Capture : Callum Bir, Director, Life Sciences, Global Industry Business Unit, ORACLE Corporation, Asia Pacific & Japan
Emerging trends in Electronic Data Capture : Callum Bir, Director, Life Sciences, Global Industry Business Unit, ORACLE Corporation, Asia Pacific & Japan

[This article was published in the August 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

Increasingly clinical trials are coming under the regulatory lense because of lack of necessary accounting of the patient and drug effects information. The following article takes a look at the new trends in electronic data capture that help track the data better.

Latest in blood glucose meter from Arkray Piramal Medical
Latest in blood glucose meter from Arkray Piramal Medical

Arkray Piramal Medical Pvt Ltd, a Joint Venture between Arkray Inc, Japan and Nicholas Piramal India Ltd a leading pharmaceutical company in India, recently released Glucocard 01, a unique and patented combination of a Ruthenium Based Mediator and Thin film carbon coated electrodes which makes the strips free from temperature and humidity interference thus ensuring accurate and precise results.

Changes in pharma CFOs roles: Ernst & Young survey
Changes in pharma CFOs roles: Ernst & Young survey

A latest Ernst & Young survey of Chief financial officers (CFOs) in the Indian pharmaceutical sector underscores important changes in the role of the CFO and the finance function in driving the success of pharmaceutical companies. Respondents of the India CFO survey envisaged a change in their responsibilities, with an increased focus on serving as business partners and managing growth.

whatsapp--v1